HuGE Literature Finder
Records 1-16
|
Retinal vein occlusion: genetic predisposition and systemic risk factors.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2013 Apr 24 (3): 279-83. Giannaki Kassiani, Politou Marianna, Rouvas Alexandros, Merkouri Efrossyni, Travlou Anthi, Theodosiadis Panayiotis, Gialeraki Argy |
|
Genetic Polymorphisms Associated with Retinal Vein Occlusion: A Greek Case-control Study and Meta-analysis.
Ophthalmic genetics 2013 Jan . Yioti GG, Panagiotou OA, Vartholomatos GA, Kolaitis NI, Pappa CN, Evangelou E, Stefaniotou MI |
|
An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis: a population-based nested case-control study.
Thrombosis research 2007 119 (4): 423-32. Hiltunen Leena, Rautanen Anna, Rasi Vesa, Kaaja Risto, Kere Juha, Krusius Tom, Vahtera Elina, Paunio Mik |
|
Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
Thrombosis research 2007 121 (3): 339-45. Cushman Mary, Cornell Alexandra, Folsom Aaron R, Wang Lu, Tsai Michael Y, Polak Joseph, Tang Zhongh |
|
ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
British journal of haematology 2006 Dec 135 (5): 697-702. Authors are not available |
|
The FXIIIVal34Leu, common and risk factors of venous thrombosis in early middle-age Costa Rican patients.
Cell Biochem Funct 2006 Dec (): . Salazar-Sánchez L, Leon MP, Cartin M, Schuster G, Wulff K, Schröder W, Jiménez-Arce G, Chacon R, Herrmann FH |
|
Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
Thrombosis and haemostasis 2006 Oct 96 (4): 465-70. Hoppe Berthold, Tolou Farzaneh, Dörner Thomas, Kiesewetter Holger, Salama Abdulgab |
|
The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2006 Oct 17 (7): 533-8. Wells Philip S, Anderson Josdalyne L, Rodger Marc A, Carson Nancy, Grimwood Rebecca L, Doucette Steve |
|
Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
American journal of epidemiology 2006 Jul 164 (2): 101-9. Wells Philip S, Anderson Josdalyne L, Scarvelis Dimitrios K, Doucette Steve P, Gagnon Fran |
|
Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome.
Lupus 2004 13 (1): 32-5. Diz-Kucukkaya R, Hancer V S, Inanc M, Nalcaci M, Pekcelen |
|
Frequency of the TAFI -438 G/A and factor XIIIA Val34Leu polymorphisms in patients with objectively proven pulmonary embolism.
Thrombosis and haemostasis 2003 Sep 90 (3): 439-45. Zidane Majida, de Visser Marieke C H, ten Wolde Marije, Vos Hans L, de Monyé Wouter, Bertina Rogier M, Huisman Menno |
|
Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.
Thrombosis research 2003 Feb 109 (4): 171-4. Ramacciotti Eduardo, Wolosker Nelson, Puech-Leao Pedro, Zeratti Eduardo Antônio, Gusson Paula Regina, del Giglio Auro, Franco Rendrik |
|
The V34L polymorphism of factor XIII and peripheral arterial disease.
International angiology : a journal of the International Union of Angiology 2002 Mar 21 (1): 53-7. Renner W, Brodmann M, Pabst E, Stanger O, Wascher T C, Pilger |
|
Factor XIII Val34Leu polymorphism and risk of deep vein thrombosis.
Thrombosis and haemostasis 2000 Dec 84 (6): 1118-9. Margaglione M, Bossone A, Brancaccio V, Ciampa A, Di Minno |
|
The FXIII Val 34 Leu mutation and the risk of venous thrombosis.
Thrombosis and haemostasis 2000 Dec 84 (6): 1117-8. Alhenc-Gelas M, Reny J L, Aubry M L, Aiach M, Emmerich |
|
Polymorphism of genes related to cardiovascular disease in patients with rheumatoid arthritis.
Clinical and experimental rheumatology 0 25 (6): 866-71. Arlestig L, Wållberg Jonsson S, Stegmayr B, Rantapää-Dahlqvist |
- Page last reviewed:Mar 16, 2019
- Page last updated:Aug 05, 2020
- Content source: